In this episode of The Oncology Insights Podcast, I speak with Dr. Lisa Carter-Bawa, Director of the Cancer Prevention Precision Control Institute at Hackensack Meridian Health, about how stigma, trust, and communication shape cancer prevention and early detection. Dr. Carter-Bawa explores lung cancer screening, patient engagement, behavioral science, and the role of community-based interventions. She also examines how emerging tools such as artificial intelligence and biomarkers intersect with patient behavior and equity. Listen now on all major platforms!

"Lung cancer screening decisions are shaped by stigma and self blame in ways that are not present in many other cancer screening contexts."

Meet the guest: Dr. Lisa Carter-Bawa is a behavioral scientist and nurse practitioner whose work focuses on stigma, trust, and engagement across the cancer prevention continuum. She leads cancer prevention research at Hackensack Meridian Health and oversees community outreach at Georgetown Lombardi Comprehensive Cancer Center. Her nationally funded research advances lung cancer screening equity through patient-centered communication. 

Liked this one? Don’t stop now. Here’s what we think you’ll love!

What you will learn:

• (00:00) Highlight
• (00:29) Introduction
• (05:56) Research roles
• (10:24) Screening foundations
• (12:37) Stigma drivers
• (14:41) Awareness gaps
• (18:52) Early detection future
• (23:35) Final Questions

𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.

Website: The Oncology Insights Podcast

Instagram: The Oncology Insights Podcast

LinkedIn: The Oncology Insights Podcast